Labiotech
VerifiedMagazine
Labiotech.eu is the leading digital media covering the European Biotech industry. Source
Actions
Media Outlet details
| Scope | Trade/B2B |
|---|---|
| Language | English |
| Country | Germany |
Similarweb UVM
|
Request pricing |
Comscore UVM
|
Request pricing |
Recent Articles
Search ArticlesEli Lilly’s pipeline in 2026: how the incretin boom is funding what comes next
Photo credits: Cytonn Photography Add Labiotech as your Google Preferred Source Newsletter Signup - Under Article / In Page "*" indicates required fields This field is for validation purposes and should be left unchanged.
Streamlining stable cell line development from the start
Photo credits: Lonza Add Labiotech as your Google Preferred Source Newsletter Signup - Under Article / In Page "*" indicates required fields This field is for validation purposes and should be left unchanged.
When every treatment counts: How clinical trials are changing the outlook for non-Hodgkin lymphoma patients
Photo credits: National Cancer Institute (Unsplash) Add Labiotech as your Google Preferred Source Newsletter Signup - Under Article / In Page "*" indicates required fields This field is for validation purposes and should be left unchanged.
Top biotech deals in August 2026
Photo credits: Mina Rad (Unsplash) Add Labiotech as your Google Preferred Source Newsletter Signup - Under Article / In Page "*" indicates required fields This field is for validation purposes and should be left unchanged.
The biggest biotech funding rounds in August 2026
Photo credits: Fabian Blank (Unsplash) Add Labiotech as your Google Preferred Source Newsletter Signup - Under Article / In Page "*" indicates required fields This field is for validation purposes and should be left unchanged.
ESC 2026: The drug development readouts that stood out
Photo credits: Patty Brito Add Labiotech as your Google Preferred Source Newsletter Signup - Under Article / In Page "*" indicates required fields This field is for validation purposes and should be left unchanged.
Investor confidence is built beyond the data
Photo credits: Cryoport Systems Add Labiotech as your Google Preferred Source Newsletter Signup - Under Article / In Page "*" indicates required fields This field is for validation purposes and should be left unchanged.
How AOCs are advancing targeted therapeutics
Image credit: MJH Shikder (Unsplash) Add Labiotech as your Google Preferred Source Newsletter Signup - Under Article / In Page "*" indicates required fields This field is for validation purposes and should be left unchanged.
Six MASH biotech companies shaping the future of liver disease treatment
Photo credits: lilartsy (Unsplash) Add Labiotech as your Google Preferred Source Newsletter Signup - Under Article / In Page "*" indicates required fields This field is for validation purposes and should be left unchanged.
Genomes to bioreactors: Saudi Arabia’s gene editing oncology push
Image credit: Ibrahim Abdullah (Unsplash) Add Labiotech as your Google Preferred Source Newsletter Signup - Under Article / In Page "*" indicates required fields This field is for validation purposes and should be left unchanged.